NEW YORK (Reuters Health) - There are clear gender
differences in the medication prescribed in primary care to
adults with or at high risk for heart disease, with women less
apt than men to receive aspirin and statins, a new study
NEW YORK (Reuters Health) - Treatment with the antiviral
interferon alfa-2b (IFN-a2b) appears to speed up virus clearance
and lower levels of key inflammatory markers in patients with
COVID-19, according to an exploratory study conducted in Wuhan,
NEW YORK (Reuters Health) - States that expanded Medicaid
under the Affordable Care Act (ACA) saw greater declines in
cancer-related deaths than states that did not, according to the
first nationwide study of its kind.
NEW YORK (Reuters Health) - A blood test can detect multiple
types of cancer in people with no history or symptoms of cancer
and can be safely incorporated into routine clinical care to
help guide patient management in real-time, leading to early
treatment, new research indicates.
NEW YORK (Reuters Health) - Adding the immune-checkpoint
inhibitor durvalumab and the PARP inhibitor olaparib to standard
neoadjuvant chemotherapy may improve outcome in women with
high-risk, HER2-negative breast cancer, according to results of
the I-SPY 2 trial.
NEW YORK (Reuters Health) - A new study has dashed hopes
that intermittent dosing of BRAF inhibitor dabrafenib and the
MEK inhibitor trametinib would be as effective as continuous
dosing of the drugs in patients with advanced BRAF-mutated
NEW YORK (Reuters Health) - Chronically ill patients
infected with multidrug-resistant organisms (MDROs) during
extensive medical care for serious conditions may benefit from
fecal microbiota transplantation (FMT), a pilot study suggests.
NEW YORK (Reuters Health) - A blood test in development can
detect cancer and tissue of origin with few false positives but
many false negatives in people suspected of having cancer before
a histologic diagnosis is made, according to a new study.
NEW YORK (Reuters Health) - The Brazilian CloroCovid-19
trial testing the safety and efficacy of a high dose of
chloroquine in patients with severe COVID-19 has been terminated
early after an interim analysis showed it was associated with
more toxic effects and deaths, particularly affecting heart
rhythms, than a lower dose.
A balanced, low-fat diet significantly lowers the risk of dying from breast cancer in postmenopausal women, according to new long-term data from the Women's Health Initiative (WHI) Dietary Modification trial.